KSKaveh Sadeghi

Kaveh Sadeghi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kaveh Sadeghi has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Development of multiplex nanopore sequencing method for the detection of multiple respiratory viruses in cases with severe acute respiratory infections

    by Arqavan Zebardast, Kaveh Sadeghi, Ahmad Nejati, Sevrin Zadheidar, Mohammad Hossein Najmi, Adel Abedi, Vahid Salimi, Mehdi Shabani, Jila Yavarian, Nazanin Zahra Shafiei-Jandaghi, et al.

    Background: Severe acute respiratory infection (SARI) remains one of the leading causes of morbidity and mortality worldwide. Multiple respiratory viral pathogens can cause this infection. Sequencing technologies hold great promise for detecting viral pathogens. This study aimed to develop and validate a method for the multiplex detection of SARI-related viruses (SARS-CoV-2, Influenza A (H1N1, H3N2), Influenza B, human respiratory syncytial virus, human adenoviruses, human enteroviruses, and human parainfluenza viruses) using a nanopore next-generation sequencing method. Methods: Following genome extraction from oropharyngeal swab samples and conventional RT-PCR assays, the libraries were barcoded and sequenced by the MinION flow cell. The sensitivity and specificity were assessed using various serial dilutions of samples and different primer pools, respectively. NGS data analysis, including adaptor trimming, assembly, mapping, and the generation of consensus sequences, was carried out using bioinformatic tools. Finally, the protocol was validated by evaluating with known positive samples. Results: During 12 hours of MinION sequencing, 711,000 reads passed the quality filters (Q-score>7). 11 out of 12 target genes were successfully identified in clinical samples, with more than 90% coverage for most viruses. All the viruses detected by Q30 value of more than 1%. The detection limit was measured for SARS-CoV-2, Influenza A (H1N1, H3N2), Influenza B, and human respiratory syncytial virus. The platform showed 99.9% specificity in detection and was validated by 20 clinical samples. Conclusion: This study developed and validated a novel multiplex detection method that made it possible to identify SARI-related respiratory viruses in a clinical laboratory setting.

  • Open Access

    Measles and Influenza A/H3N2 Coinfection in a Measles Suspected Infant from Iran

    by Alireza Esmaeiloghli, Kaveh Sadeghi, Nazanin Shafiei Jandaghi, Vahid Salimi, Jila Yavarian, Sevrin Zadheidar, Talat Mokhtari-Azad

    Measles is an acute infectious disease which is highly contagious. This illness is caused by a negative sense, single-stranded RNA virus belonging to the Paramyxoviridae family. In spite of having a highly effective vaccine, measles is still a public health concern. In October 2019, Iran has achieved the status of measles elimination using effective vaccination strategies and surveillance system based on WHO recommendations. However, recent COVID-19 pandemic disrupted impeccable immunization services and altered health-seeking behaviors worldwide. Herein, we report a case of measles and influenza co-infection in a nine month-old infant from Bushehr province of Iran

  • Open Access

    SARS‐CoV ‐2 in patient with protein C deficiency: A case report

    by Akram Sadat Ahmadi, Nazanin Zahra Shafiei‐Jandaghi, Kaveh Sadeghi, Vahid Salimi, Ahmad Nejati, Talat Mokhtari Azad, Jila Yavarian

    Key clinical message: In SARS‐CoV‐2 pandemic different disorders in coagulation pathways in COVID‐19 patients were reported. We described a 44‐year‐old female with COVID‐19 and protein C deficiency history. She did not show any coagulation disorder during her disease course. Complete genome sequencing of SARS‐CoV‐2 was performed and some mutations identified and compared with Wuhan strain. Besides hospitalized patients, in COVID‐19 outpatients with low concentration of protein C, early prescription of an anticoagulant such as heparin could be helpful in prevention of venous thromboembolism or pulmonary embolism.

  • SARS‐CoV‐2 intrahost evolution in immunocompromised patients in comparison with immunocompetent populations after treatment

    by Akram Sadat Ahmadi, Sevrin Zadheidar, Kaveh Sadeghi, Ahmad Nejati, Vahid Salimi, Mahboobeh Hajiabdolbaghi, Talat Mokhtari‐Azad, Jila Yavarian

    Many evidence suggests that long‐lasting infection can develop with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). This occurrence has been widely described in immunocompromised individuals. In these patients, ineffective clearance of virus infection provides an opportunity for developing immune escape mutants. This study aimed to characterize SARS‐CoV‐2 intrahost evolution in five immunocompromised in comparison with five immunocompetent COVID‐19 patients during treatment. We performed next‐generation sequencing (NGS) on collected two oropharyngeal samples from immunocompromised and immunocompetent COVID‐19 patients before and after treatment. In this study, we detected alpha and delta variants of SARS‐CoV‐2. The most common substitutions in structural proteins in patients with alpha variant were S‐ΔY143‐144, A570D, D614G and D1118H, and N‐R203K and G204R, and in delta variant S‐T19R, G142D, E156G, 157‐158del, L452R, T478K, D614G, D950N and N‐D63G, R203M and D377Y were dominant. The common variations in nonstructural and accessory proteins including nsp3‐A488S, P1228L, nsp6‐T77A, nsp12‐P323L, G671S, nsp13‐P77L, NS3‐S26L, and NS7a‐T120I were detected. Also some infrequent substitutions were seen in immunocompromised and immunocompetent patients. After treatment, nsp12‐V166A was emerged as a remdesivir resistance and S‐L452M in a patient with common variable immunodeficiency. S‐E484Q was detected in a patient with acute lymphoma leukemia. This study showed the possibility of the genetic diversity and development of some new mutations in immunocompromised patients. Therefore, surveillance of these patients to characterize any new variants is necessary.


  • Open Access

    Surveillance of endemic coronaviruses during the COVID‐19 pandemic in Iran, 2021–2022

    by Hassan Karami, Kaveh Sadeghi, Sevrin Zadheidar, Fatemeh Saadatmand, Negar Mirsalehi, Nima Hoveidi Ardestani, Shirin Kalantari, Mohammad Farahmand, Jila Yavarian, Talat Mokhtari‐Azad

    Background: Human coronaviruses (HCoVs) 229E, OC43, HKU1, and NL63 are common viruses that continuously circulate in the human population. Previous studies showed the circulation of HCoVs during the cold months in Iran. We studied the circulation of HCoVs during coronavirus disease 2019 (COVID‐19) pandemic to find the impact of pandemic on the circulation of these viruses.Methods: As a cross‐sectional survey conducted during 2021 to 2022, of all throat swabs sent to Iran National Influenza Center from patients with severe acute respiratory infection, 590 samples were selected to test for HCoVs using one‐step real‐time RT‐PCR.Results: Overall, 28 out of 590 (4.7%) tested samples were found to be positive for at least one HCoVs. HCoV‐OC43 was the most common (14/590 or 2.4%), followed by HCoV‐HKU1 (12/590 or 2%) and HCoV‐229E (4/590 or 0.6%), while HCoV‐NL63 was not detected. HCoVs were detected in patients of all ages and throughout the study period with peaks in the cold months of the year.Conclusions: Our multicenter survey provides insight into the low circulation of HCoVs during the COVID‐19 pandemic in Iran in 2021/2022. Hygiene habits and social distancing measures might have important role in decreasing of HCoVs transmission. We believe that surveillance studies are needed to track the pattern of HCoVs distributions and detect changes in the epidemiology of such viruses to set out strategies in order to timely control the future outbreaks of HCoVs throughout the nation.


  • Sudden Onset of Decreased Vision Following Delta Variant of SARS-CoV-2 Infection: A Case Report

    by Akram Sadat Ahmadi, Nazanin Zahra Shafiei-Jandaghi, Kaveh Sadeghi, Mohammadreza Salehi, Talat Mokhtari-Azad, Jila Yavarian

    We described a 52-year-old male patient with COVID-19 who had sudden decreased vision in his left eye in the second week of his illness. No occlusion thrombotic vein or hemorrhagic spots in retina ...